Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Economic analyses and clinical practice guidelines: why not a match made in heaven?

× No keyword cloud information.

16 in total

Review 1. Design issues for conducting cost-effectiveness analyses alongside clinical trials.

Authors: S D Ramsey; M McIntosh; S D Sullivan
Journal: Annu Rev Public Health Date: 2001 Impact factor: 21.981

2. Problems with the interpretation of pharmacoeconomic analyses: a review of submissions to the Australian Pharmaceutical Benefits Scheme.

Authors: S R Hill; A S Mitchell; D A Henry
Journal: JAMA Date: 2000-04-26 Impact factor: 56.272

3. Evaluation of conflict of interest in economic analyses of new drugs used in oncology.

Authors: M Friedberg; B Saffran; T J Stinson; W Nelson; C L Bennett
Journal: JAMA Date: 1999-10-20 Impact factor: 56.272

4. A comprehensive league table of cost-utility ratios and a sub-table of "panel-worthy" studies.

Authors: R H Chapman; P W Stone; E A Sandberg; C Bell; P J Neumann
Journal: Med Decis Making Date: 2000 Oct-Dec Impact factor: 2.583

5. The impact of pipeline drugs on drug spending growth.

Authors: C D Mullins; J Wang; F B Palumbo; B Stuart
Journal: Health Aff (Millwood) Date: 2001 Sep-Oct Impact factor: 6.301

Review 6. The limited incorporation of economic analyses in clinical practice guidelines.

Authors: Joel F Wallace; Scott R Weingarten; Chiun-Fang Chiou; James M Henning; Andriana A Hohlbauch; Margaret S Richards; Nicole S Herzog; Lior S Lewensztain; Joshua J Ofman
Journal: J Gen Intern Med Date: 2002-03 Impact factor: 5.128

7. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.

Authors: A Laupacis; D Feeny; A S Detsky; P X Tugwell
Journal: CMAJ Date: 1992-02-15 Impact factor: 8.262

Review 8. The effectiveness of cost-effectiveness analysis in containing costs.

Authors: N A Azimi; H G Welch
Journal: J Gen Intern Med Date: 1998-10 Impact factor: 5.128

9. Can the health utilities index measure change?

Authors: J A Kopec; S E Schultz; V Goel; J Ivan Williams
Journal: Med Care Date: 2001-06 Impact factor: 2.983

10. Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem.

Authors: A Gafni; S Birch
Journal: CMAJ Date: 1993-03-15 Impact factor: 8.262

3 in total

1. Evidence and advocacy: are all things considered?

Authors: Jeffrey A Johnson; Alun L Edwards
Journal: CMAJ Date: 2006-06-20 Impact factor: 8.262

2. Predictors of the growing influence of clinical practice guidelines.

Authors: Ann S O'malley; Hoangmai H Pham; James D Reschovsky
Journal: J Gen Intern Med Date: 2007-03-27 Impact factor: 5.128

3. Incorporating cost-effectiveness data in a fair process for priority setting efforts Comment on "Use of cost-effectiveness data in priority setting decisions: experiences from the national guidelines for heart diseases in Sweden".

Authors: Sitaporn Youngkong
Journal: Int J Health Policy Manag Date: 2015-04-11

3 in total